Picture of Charles River Laboratories International logo

CRL Charles River Laboratories International Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Annual cashflow statement for Charles River Laboratories International, fiscal year end - December 28th, USD millions except per share, conversion factor applied.

2020
December 26th
2021
December 25th
2022
December 31st
2023
December 30th
2024
December 28th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line36539949348025.3
Depreciation
Deferred Taxes
Non-Cash Items-27.277.511.642.7445
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-26.342.9-153-102-30.3
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities547761620684735
Capital Expenditures-167-229-325-319-233
Purchase of Fixed Assets
Other Investing Cash Flow Items-435-1,209-283-245-12.1
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-602-1,438-608-563-245
Financing Cash Flow Items-5.95-40.6-48.6-11.6-43.4
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities47.2673-42.4-85.5-551
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-6.9313.2-5.143.3-78.9